RAMM Pharma Corp. Provides Update on Litigation
May 21, 2024 17:01 ET
|
RAMM Pharma Corp.
Not for Dissemination in the US or through US Newswire Services TORONTO, May 21, 2024 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE:...
RAMM Pharma Corp. Announces Corporate Update
March 28, 2024 15:49 ET
|
RAMM Pharma Corp.
TORONTO, March 28, 2024 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), is pleased to advise its shareholders that in accordance...
RAMM Pharma Corp. Announces Corporate Update.
November 17, 2023 18:56 ET
|
RAMM Pharma Corp.
TORONTO, Nov. 17, 2023 (GLOBE NEWSWIRE) -- On September 5th 2023, RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), announced its intention to...
RAMM Pharma Corp. Announces Corporate Update
October 11, 2023 11:49 ET
|
RAMM Pharma Corp.
TORONTO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- On September 5th, 2023, RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), announced its intention to...
RAMM Pharma Corp. Announces Corporate Update
September 12, 2023 09:59 ET
|
RAMM Pharma Corp.
TORONTO, Sept. 12, 2023 (GLOBE NEWSWIRE) -- On September 5th 2023, RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), announced its intention to...
RAMM Pharma Corp. Announces Non-Brokered Private Placement and Intention to Commence Normal Course Issuer Bid
September 05, 2023 17:37 ET
|
RAMM Pharma Corp.
TORONTO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), announces that it intends to complete a non-brokered...